International AIDS Society International AIDS Society Blog | International AIDS Society Blog | International AIDS Society

Development of pre-exposure prophylaxis (PrEP) for women discussed at the Satellite Session: “Expanding HIV Prevention Options for Women”

Posted 28 juin 2013, 05:56 , by Guest

By the International AIDS Society – Industry Liaison Forum (ILF)

Despite very high efficacy displayed in some clinical trials, PrEP was also shown to suffer from worrying limitations, at least in part related to adherence problems. Although the FDA has approved PrEP (Truvada: trademark for emtricitabine/tenofovir disoproxil fumarate, Gilead Sciences), further discussion is warranted and new product formulations and/or delivery mechanisms need to be developed.

To further the reflexion on this topic, the International AIDS Society – Industry Liaison
Forum
(IAS-ILF) and AVAC co-organize a satellite session entitled “Expanding HIV Prevention Option for Women” as part of the programme of the 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013).

This session will include an overview presentation entitled “What do we know about PrEP in women?” followed by two moderated panel discussions. The first panel, under the supervision of Cate Hankins (Amsterdam Institute of Global Health and Development, Netherlands) will discuss the available data on PrEP, particularly for women and with a special focus on the recent results from the VOICE trial. The second panel, with Mitchell Warren (AVAC, USA) acting as the moderator, will look beyond the current situation, highlighting how new products should be developed for different target populations, i.e. how technology and implementation strategies (taking into consideration motivation, risk perception, adherence, and life style) can help overcome some of the challenges inherent to PrEP.

The two-hour satellite session will follow-up on the CROI 2013 IAS-ILF affiliated event on “Sex and Gender Differences in ARV-Based Prevention Research” and will be co-chaired by Linda-Gail Bekker (Desmond Tutu HIV Centre, South Africa) and Mitchell Warren (AVAC, USA) and will include participants from different horizons.

The Satellite Session “Expanding HIV Prevention Options for Women” will take place on Sunday, 30 June, from 17:00-19:00 in Mini Room 3 of the Kuala Lumpur Convention Centre. More information is available online: IAS-ILF website and through the IAS 2013 Programme-at-a-Glance (PAG).